rs2303113

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_006949.4(STXBP2):​c.1696+20A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0424 in 1,580,132 control chromosomes in the GnomAD database, including 7,649 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.093 ( 1506 hom., cov: 32)
Exomes 𝑓: 0.037 ( 6143 hom. )

Consequence

STXBP2
NM_006949.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.0560
Variant links:
Genes affected
STXBP2 (HGNC:11445): (syntaxin binding protein 2) This gene encodes a member of the STXBP/unc-18/SEC1 family. The encoded protein is involved in intracellular trafficking, control of SNARE (soluble NSF attachment protein receptor) complex assembly, and the release of cytotoxic granules by natural killer cells. Mutations in this gene are associated with familial hemophagocytic lymphohistiocytosis. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jan 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 19-7647531-A-G is Benign according to our data. Variant chr19-7647531-A-G is described in ClinVar as [Benign]. Clinvar id is 260099.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.466 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
STXBP2NM_006949.4 linkc.1696+20A>G intron_variant Intron 18 of 18 ENST00000221283.10 NP_008880.2 Q15833-1Q53GF4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
STXBP2ENST00000221283.10 linkc.1696+20A>G intron_variant Intron 18 of 18 1 NM_006949.4 ENSP00000221283.4 Q15833-1
ENSG00000268400ENST00000698368.1 linkn.*1819A>G downstream_gene_variant ENSP00000513686.1 A0A8V8TM65

Frequencies

GnomAD3 genomes
AF:
0.0933
AC:
14152
AN:
151726
Hom.:
1498
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.188
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.106
Gnomad ASJ
AF:
0.0364
Gnomad EAS
AF:
0.482
Gnomad SAS
AF:
0.0922
Gnomad FIN
AF:
0.0719
Gnomad MID
AF:
0.0316
Gnomad NFE
AF:
0.0120
Gnomad OTH
AF:
0.0717
GnomAD3 exomes
AF:
0.0834
AC:
16397
AN:
196508
Hom.:
2109
AF XY:
0.0771
AC XY:
8209
AN XY:
106442
show subpopulations
Gnomad AFR exome
AF:
0.191
Gnomad AMR exome
AF:
0.100
Gnomad ASJ exome
AF:
0.0330
Gnomad EAS exome
AF:
0.479
Gnomad SAS exome
AF:
0.0737
Gnomad FIN exome
AF:
0.0653
Gnomad NFE exome
AF:
0.0115
Gnomad OTH exome
AF:
0.0484
GnomAD4 exome
AF:
0.0369
AC:
52760
AN:
1428288
Hom.:
6143
Cov.:
74
AF XY:
0.0372
AC XY:
26363
AN XY:
707920
show subpopulations
Gnomad4 AFR exome
AF:
0.194
Gnomad4 AMR exome
AF:
0.100
Gnomad4 ASJ exome
AF:
0.0326
Gnomad4 EAS exome
AF:
0.491
Gnomad4 SAS exome
AF:
0.0712
Gnomad4 FIN exome
AF:
0.0636
Gnomad4 NFE exome
AF:
0.00958
Gnomad4 OTH exome
AF:
0.0612
GnomAD4 genome
AF:
0.0934
AC:
14185
AN:
151844
Hom.:
1506
Cov.:
32
AF XY:
0.0992
AC XY:
7362
AN XY:
74230
show subpopulations
Gnomad4 AFR
AF:
0.188
Gnomad4 AMR
AF:
0.106
Gnomad4 ASJ
AF:
0.0364
Gnomad4 EAS
AF:
0.482
Gnomad4 SAS
AF:
0.0923
Gnomad4 FIN
AF:
0.0719
Gnomad4 NFE
AF:
0.0120
Gnomad4 OTH
AF:
0.0714
Alfa
AF:
0.0469
Hom.:
102
Bravo
AF:
0.101
Asia WGS
AF:
0.258
AC:
894
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 21% of patients studied by a panel of primary immunodeficiencies. Number of patients: 20. Only high quality variants are reported. -

-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Nov 12, 2018
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Familial hemophagocytic lymphohistiocytosis 5 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
1.9
DANN
Benign
0.63
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2303113; hg19: chr19-7712417; COSMIC: COSV55406351; COSMIC: COSV55406351; API